Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A combined protocol for this situation might involve starting BPC-157 at 250 mcg twice daily, with subcutaneous injection approximately 1-2 inches lateral to the patellar tendon
When stored properly at -20C in a sealed container away from direct light and moisture, lyophilized GHK-Cu remains stable for 24-36 months from the date of manufacture
Book an appointment with Prestige RM to discuss pricing and payment options
BPC-157 : TB500 : KPV : BTK Complex (BPC-157 | TB500 | KPV) CERTIFICATES OF ANALYSIS 3 COAs BN-26BTK30-001 Current Variant: Size: btk-30 BPC-157 11.5 mg / 11.42 mg TB-500 11.41 mg / 11.35 mg KPV 10.83 mg / 10.75 mg BN-25BTK20-001 Current Variant: Size: btk-20 BPC-157 5.49 mg / 5.29 mg TB-500 11.78 mg / 11.21 mg KPV 3.88 mg / 3.61 mg BBN-26BTK20-001 Upcoming Variant: Size: btk-20 BPC-157 6.01 mg / 5.72 mg TB-500 11.7 mg / 11.04 mg KPV 5.8 mg / 5.52 mg Formulation BTK is a multi-peptide research formulation combining BPC-157, TB-500 (Thymosin Beta-4 fragment), and KPV, supplied for use in controlled laboratory and analytical environments
Both conditions share symptoms such as: Abdominal pain and cramping Frequent diarrhea or urgency Fatigue and unintended weight loss Blood or mucus in the stool Its important to note that IBD is not the same as IBS (Irritable Bowel Syndrome)
Applied twice daily using 0.5ml per application, this provides 20mg per day of topical peptide (though actual absorption is much lower due to skin penetration limits)
